AWM
SRPT icon

Activest Wealth Management’s Sarepta Therapeutics SRPT Stock Holding History

Activest Wealth Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.1K Sell
395
-383
-49% -$7.24K ﹤0.01% 656
2026
Q1 		$16.9K Sell
778
-2
-0.3% -$39 ﹤0.01% 567
2025
Q4 		$16.8K Buy
780
+738
+1,757% +$15.6K ﹤0.01% 552
2025
Q3 		$809 Buy
+42
New +$749 ﹤0.01% 899

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Activest Wealth Management's SRPT Position: Q2 2026 in Review

Activest Wealth Management reduced its Sarepta Therapeutics (SRPT) stake by 49% in Q2 2026, selling an estimated $7.24K and leaving 395 shares worth $7.1K. The position accounts for ﹤0.01% of the portfolio, ranked #656.

Activest Wealth Management first reported a position in SRPT in Q3 2025 and has held it in 4 quarters since. The position peaked at $16.9K in Q1 2026. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Activest Wealth Management held 395 shares of Sarepta Therapeutics worth $7.1K as of Q2 2026.
  • Activest Wealth Management sold 383 Sarepta Therapeutics shares in Q2 2026, an estimated $7.24K.
  • Sarepta Therapeutics made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #656 holding.
  • Activest Wealth Management first reported a position in Sarepta Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Activest Wealth Management's Sarepta Therapeutics position peaked at $16.9K in Q1 2026.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.